PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| +18.20p | +2.03% | 914.70p | 910.30p | 912.00p | 925.00p | 871.00p | 871.00p | 144,953 | 16:35:10 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 37.6 | -11.8 | -0.3 | - | 604.07 |
Oxford Biomedica (OXB) News Headlines
Oxford Biomedica News
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/9/2018 | 06:05 | ALNCF |  Alliance News Flash Headline |
| 13/9/2018 | 11:01 | ALNC | Oxford Biomedica Swings To Profit On Bioverativ And Axovant Deals |
| 13/9/2018 | 07:01 | UKREG | Oxford Biomedica PLC Oxford BioMedica Interim Results |
| 13/9/2018 | 07:00 | UKREG | Oxford Biomedica PLC Oxford BioMedica further capacity expansion |
| 03/9/2018 | 09:18 | UKREG | Oxford Biomedica PLC Total Voting Rights |
| 28/8/2018 | 11:30 | ALNC | European Commission Approves Oxford BioMedica's Kymriah Therapy |
| 28/8/2018 | 07:01 | UKREG | Oxford Biomedica PLC Kymriah® receives European Commission Approval |
| 22/8/2018 | 11:58 | UKREG | Oxford Biomedica PLC Director/PDMR Shareholding |
| 15/8/2018 | 07:00 | UKREG | Oxford Biomedica PLC RNS notice of results OXB |
| 13/8/2018 | 10:55 | UKREG | Oxford Biomedica PLC Director/PDMR Shareholding |
1 Year Oxford Biomedica Chart |
Intraday Oxford Biomedica Chart |
